Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- MICT -6.5%, BITA -4.9%
Other news:
- BIOC -10% (files for $10 mln mixed securities shelf offering)
- MVIS -8.9% (files for $60 mln mixed securities shelf offering)
- BIVV -6.3% (down following positive Hemophilia A data from Roche)
- UQM -4.2% (files for 30 mln share common stock offering by selling stockholder)
- SHPG -3.9% (down following positive Hemophilia A data from Roche)
- ACOR -2.5% (to discontinue its clinical development program for tozadenant)
Analyst comments:
- GAIN -2.7% (downgraded to Neutral from Outperform at Wedbush)
- CAH -2.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- .MNST -2.3% (downgraded to Negative at from Neutral Susquehanna)
- JACK -1% (downgraded to Neutral from Outperform at Wedbush)
- CROX -1% (downgraded to Neutral from Buy at CL King)
- WMT -0.9% (downgraded to Neutral from Buy at Goldman)